VANCOUVER, Wash., July 24, 2025 (GLOBE NEWSWIRE) — Absci Corporation (Nasdaq: ABSI) (“Absci”), a clinical-stage biopharmaceutical company advancing potential breakthrough therapeutics designed with generative AI,…
Curated SPACs News
VANCOUVER, Wash., July 24, 2025 (GLOBE NEWSWIRE) — Absci Corporation (Nasdaq: ABSI) (“Absci”), a clinical-stage biopharmaceutical company advancing potential breakthrough therapeutics designed with generative AI,…